NCT04527276View on ClinicalTrials.gov

Reducing the Incidence of VAP in Critically Ill Children and Assessment of Oral Care With CHX

NACompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

January 1, 2020

Study Completion Date

January 31, 2020

Conditions
Ventilator Associated Pneumonia
Interventions
OTHER

Oral care with 0,12% Chlorhexidine

0, 12 % CHX, and standard oral care with 0,9% NaCl were compared to assess VAP rates. Both solutions were applied to critically ill children who were intubated.

Trial Locations (1)

Unknown

Istanbul Medeniyet University, Istanbul

All Listed Sponsors
lead

Istanbul Medeniyet University

OTHER

NCT04527276 - Reducing the Incidence of VAP in Critically Ill Children and Assessment of Oral Care With CHX | Biotech Hunter | Biotech Hunter